|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q1 FY2022
As of Oct 31, 2021
|
Q4 FY2021
As of Jul 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Oil and gas properties | ||||||||||||||||||||
| Oil and Gas Properties | ||||||||||||||||||||
| Total oil and gas properties | ||||||||||||||||||||
| Other asset | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Loans payable - current | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total loans payable - current | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long Term Liabilities: | ||||||||||||||||||||
| Other payables | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Loan payable – long term | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total loan payable – long term | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Stockholders’ Deficit: | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 50,000,000 shares authorized; no shares issued | ||||||||||||||||||||
| Common stock, $0.001 par value, 250,000,000 shares authorized; 111,488,932 and 107,238,932 shares issued and outstanding as of April 30, 2026 and July 31, 2025, respectively | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
Loading...
